Literature DB >> 33256439

Fifty Years of Research on Schizophrenia: The Ascendance of the Glutamatergic Synapse.

Joseph T Coyle1, W Brad Ruzicka1, Darrick T Balu1.   

Abstract

Entities:  

Keywords:  Antipsychotics; Genetics/Genomics; History of Psychiatry; Neuropathology; Schizophrenia Spectrum and Other Psychotic Disorders

Mesh：

Substances：

Year:  2020        PMID： 33256439      PMCID： PMC8011846          DOI： 10.1176/appi.ajp.2020.20101481

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  123 in total

1.  Chlorpromazine and neuroleptic treatments in psychiatry.

Authors:  J DELAY; P DENIKER
Journal:  J Clin Exp Psychopathol       Date:  1956 Jan-Mar

Review 2.  NMDA receptors and schizophrenia.

Authors:  Lars V Kristiansen; Ibone Huerta; Monica Beneyto; James H Meador-Woodruff
Journal:  Curr Opin Pharmacol       Date:  2006-11-09       Impact factor: 5.547

Review 3.  Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.

Authors:  John E Lisman; Joseph T Coyle; Robert W Green; Daniel C Javitt; Francine M Benes; Stephan Heckers; Anthony A Grace
Journal:  Trends Neurosci       Date:  2008-04-07       Impact factor: 13.837

4.  Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons.

Authors:  S B Floresco; C L Todd; A A Grace
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

5.  Functional magnetic resonance imaging studies of schizophrenic patients during word production: effects of D-cycloserine.

Authors:  Deborah A Yurgelun-Todd; Joseph T Coyle; Staci A Gruber; Perry F Renshaw; Marisa M Silveri; Edward Amico; Bruce Cohen; Donald C Goff
Journal:  Psychiatry Res       Date:  2005-01-30       Impact factor: 3.222

6.  Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse.

Authors:  Patrick O McGowan; Aya Sasaki; Ana C D'Alessio; Sergiy Dymov; Benoit Labonté; Moshe Szyf; Gustavo Turecki; Michael J Meaney
Journal:  Nat Neurosci       Date:  2009-03       Impact factor: 24.884

7.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

Authors:  J H Krystal; L P Karper; J P Seibyl; G K Freeman; R Delaney; J D Bremner; G R Heninger; M B Bowers; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1994-03

8.  Changes in plasma D-serine, L-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment.

Authors:  Hidenaga Yamamori; Ryota Hashimoto; Yuko Fujita; Shusuke Numata; Yuka Yasuda; Michiko Fujimoto; Kazutaka Ohi; Satomi Umeda-Yano; Akira Ito; Tetsuro Ohmori; Kenji Hashimoto; Masatoshi Takeda
Journal:  Neurosci Lett       Date:  2014-09-10       Impact factor: 3.046

9.  Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis.

Authors:  Cathy Davies; Giulia Segre; Andrés Estradé; Joaquim Radua; Andrea De Micheli; Umberto Provenzani; Dominic Oliver; Gonzalo Salazar de Pablo; Valentina Ramella-Cravaro; Maria Besozzi; Paola Dazzan; Maddalena Miele; Gianluigi Caputo; Cecilia Spallarossa; Georgia Crossland; Athif Ilyas; Giulia Spada; Pierluigi Politi; Robin M Murray; Philip McGuire; Paolo Fusar-Poli
Journal:  Lancet Psychiatry       Date:  2020-03-24       Impact factor: 27.083

Review 10.  Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies.

Authors:  Filippo Varese; Feikje Smeets; Marjan Drukker; Ritsaert Lieverse; Tineke Lataster; Wolfgang Viechtbauer; John Read; Jim van Os; Richard P Bentall
Journal:  Schizophr Bull       Date:  2012-03-29       Impact factor: 9.306
View more
  8 in total

1.  Pharmacological rescue in patient iPSC and mouse models with a rare DISC1 mutation.

Authors:  Nam-Shik Kim; Zhexing Wen; Jing Liu; Ying Zhou; Ziyuan Guo; Chongchong Xu; Yu-Ting Lin; Ki-Jun Yoon; Junhyun Park; Michelle Cho; Minji Kim; Xinyuan Wang; Huimei Yu; Srilatha Sakamuru; Kimberly M Christian; Kuei-Sen Hsu; Menghang Xia; Weidong Li; Christopher A Ross; Russell L Margolis; Xin-Yun Lu; Hongjun Song; Guo-Li Ming
Journal:  Nat Commun       Date:  2021-03-03       Impact factor: 14.919

2.  Gene set enrichment analysis of pathophysiological pathways highlights oxidative stress in psychosis.

Authors:  Giorgio Pistis; Javier Vázquez-Bourgon; Margot Fournier; Raoul Jenni; Martine Cleusix; Sergi Papiol; Sophie E Smart; Antonio F Pardiñas; James T R Walters; James H MacCabe; Zoltán Kutalik; Philippe Conus; Benedicto Crespo-Facorro; Kim Q Do
Journal:  Mol Psychiatry       Date:  2022-09-21       Impact factor: 13.437

3.  Pathway-specific contribution of parvalbumin interneuron NMDARs to synaptic currents and thalamocortical feedforward inhibition.

Authors:  Eastman M Lewis; Hayli E Spence; Neha Akella; Andres Buonanno
Journal:  Mol Psychiatry       Date:  2022-09-08       Impact factor: 13.437

Review 4.  Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia.

Authors:  Michel Cuenod; Pascal Steullet; Jan-Harry Cabungcal; Daniella Dwir; Ines Khadimallah; Paul Klauser; Philippe Conus; Kim Q Do
Journal:  Mol Psychiatry       Date:  2021-11-10       Impact factor: 13.437

5.  Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain.

Authors:  Arianna De Rosa; Andrea Fontana; Tommaso Nuzzo; Martina Garofalo; Anna Di Maio; Daniela Punzo; Massimiliano Copetti; Alessandro Bertolino; Francesco Errico; Antonio Rampino; Andrea de Bartolomeis; Alessandro Usiello
Journal:  Schizophrenia (Heidelb)       Date:  2022-02-25

Review 6.  Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D3 Receptors in the Brain in vivo.

Authors:  Béla Kiss; Balázs Krámos; István Laszlovszky
Journal:  Front Psychiatry       Date:  2022-03-24       Impact factor: 4.157

7.  Reduced d-serine levels drive enhanced non-ionotropic NMDA receptor signaling and destabilization of dendritic spines in a mouse model for studying schizophrenia.

Authors:  Deborah K Park; Samuel Petshow; Margarita Anisimova; Eden V Barragan; John A Gray; Ivar S Stein; Karen Zito
Journal:  Neurobiol Dis       Date:  2022-05-20       Impact factor: 7.046

Review 8.  An alternative splicing hypothesis for neuropathology of schizophrenia: evidence from studies on historical candidate genes and multi-omics data.

Authors:  Chu-Yi Zhang; Xiao Xiao; Zhuohua Zhang; Zhonghua Hu; Ming Li
Journal:  Mol Psychiatry       Date:  2021-03-08       Impact factor: 15.992
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.